Literature DB >> 8364029

Dimerization and tetramerization properties of the C-terminal region of chromogranin A: a thermodynamic analysis.

S H Yoo1, M S Lewis.   

Abstract

Chromogranin A, which is a high-capacity, low-affinity Ca2+ binding protein, has recently been shown to exist in monomer-dimer and in monomer-tetramer equilibria at pH 7.5 and 5.5, respectively [Yoo, S. H., & Lewis, M. S. (1992) J. Biol. Chem. 267, 11236-11241]. The pH appeared to be a necessary and sufficient factor determining the types of oligomer formed. In the present study, using 14 synthetic peptides representing various portions of chromogranin A, we have identified a region in chromogranin A which exhibited dimerization and tetramerization properties at pH 7.5 and 5.5, respectively. Of the 14 peptides, only the conserved C-terminal region (residues 407-431), represented by peptide 14, showed the oligomerization property, existing in a dimeric state at pH 7.5 and in a tetrameric state at pH 5.5. The delta G degrees values of tetramerization were approximately -18.0 kcal/mol, and the delta G degrees value of dimerization was -4.6 kcal/mol. Although peptide 14 represented only 6% of the entire sequence, the delta G degrees value of -18.0 kcal/mol accounted for 80-83% of the delta G degrees values (-21.6 to -22.7 kcal/mol) of tetramerization of intact chromogranin A. Unlike the tetramerization mechanisms of intact chromogranin A where the presence of 35 mM Ca2+ changed the tetramerization mechanism from an enthalpically driven to an entropically driven reaction, the tetramerization mechanism of peptide 14 remained entropically driven regardless of the presence of Ca2+. Likewise, dimerization of the peptide was also entropically driven.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364029     DOI: 10.1021/bi00085a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Chromogranin A as a crucial factor in the sorting of peptide hormones to secretory granules.

Authors:  Salah Elias; Charlène Delestre; Maite Courel; Youssef Anouar; Maite Montero-Hadjadje
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

2.  Temperature dependence of release of vesicular content in bovine chromaffin cells.

Authors:  A Walker; M I Glavinović; J Trifaró
Journal:  Pflugers Arch       Date:  1996-09       Impact factor: 3.657

3.  Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance.

Authors:  Francis Schneider; Charlotte Bach; Hélène Chung; Luca Crippa; Thomas Lavaux; Pierre-Edouard Bollaert; Michel Wolff; Angelo Corti; Anne Launoy; Xavier Delabranche; Thierry Lavigne; Nicolas Meyer; Patrick Garnero; Marie-Hélène Metz-Boutigue
Journal:  Intensive Care Med       Date:  2012-06-16       Impact factor: 17.440

Review 4.  Secretory vesicle pools and rate and kinetics of single vesicle exocytosis in neurosecretory cells.

Authors:  J M Trifaró; M Glavinovic; S D Rosé
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

5.  Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides.

Authors:  Maité Montero-Hadjadje; Salah Elias; Laurence Chevalier; Magalie Benard; Yannick Tanguy; Valérie Turquier; Ludovic Galas; Laurent Yon; Maria M Malagon; Azeddine Driouich; Stéphane Gasman; Youssef Anouar
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

6.  Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells.

Authors:  Soren K Thomsen; Anne Raimondo; Benoit Hastoy; Shahana Sengupta; Xiao-Qing Dai; Austin Bautista; Jenny Censin; Anthony J Payne; Mahesh M Umapathysivam; Aliya F Spigelman; Amy Barrett; Christopher J Groves; Nicola L Beer; Jocelyn E Manning Fox; Mark I McCarthy; Anne Clark; Anubha Mahajan; Patrik Rorsman; Patrick E MacDonald; Anna L Gloyn
Journal:  Nat Genet       Date:  2018-07-27       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.